Trial Profile
Clinical Trials Insight: 700024268
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2007
Price :
$35
*
At a glance
- Drugs Bederocin (Primary)
- Indications Bacterial infections; Impetigo; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors Cardiovascular Systems
- 02 Jul 2007 New trial record.